youngen

youngen

Youngen, based in Beijing, is a biotechnology company pioneering the development of next-generation siRNA drugs to silence specific mRNAs and reduce the production of proteins that cause disease. Youngen has been dedicating to bring RNAi therapeutics to a broad spectrum of difficult-to-treat diseases, both rare and general population impacting millions of people around the world. Leveraging these platform technologies, we built diversified product pipelines with globally competitive, first-in-class and best-in-class potential. We’re exploring many therapeutic areas to bring more treatment options to the patients with metabolic and cardiovascular diseases, immune-mediated diseases, and neurological disorders. https://www.youngenbiomed.com/
49 Hits youngen Sep 10, 2025, 3:17 PM
Hair loss is a type of skin disease, and the common types of hair loss are mainly divided into androgenic alopecia, alopecia areata, psychogenic alopecia, genetic alopecia, etc. 95% of the hair loss belongs to androgenic alopecia.
Read More
57 Hits youngen Sep 10, 2025, 3:14 PM
Advantages of Technological Platforms Youngen has developed a Fast Integrated Screening Technology called FlSTsiran that is uniquely positioned to rapidly identify...
Read More
58 Hits youngen Sep 10, 2025, 3:13 PM
Cardiovascular metabolic system diseases have become a global health crisis, affecting the quality of life and health status of people. Cardiovascular...
Read More
50 Hits youngen Sep 10, 2025, 3:12 PM
Central nervous system diseases refer to a group of diseases caused by chronic progressive degeneration of central nervous system tissues....
Read More
49 Hits youngen Sep 10, 2025, 3:11 PM
Cardiovascular metabolic system diseases Cardiovascular metabolic disease is a kind of diseases that seriously endangers human health, mainly including hypertension, hyperlipidemia,...
Read More
76 Hits youngen Aug 14, 2025, 9:06 AM
Youngen, based in Beijing, is a biotechnology company pioneering the development of next-generation siRNA drugs to silence specific mRNAs and reduce the production of proteins that cause disease. Youngen has been dedicating to bring RNAi therapeutics to a broad spectrum of difficult-to-treat diseases, both rare and general population impacting millions of people around the world. Leveraging these platform technologies, we built diversified product pipelines with globally competitive, first-in-class and best-in-class potential. We’re exploring many therapeutic areas to bring more treatment options to the patients with metabolic and cardiovascular diseases, immune-mediated diseases, and neurological disorders.
Read More
62 Hits youngen Aug 14, 2025, 9:05 AM
Youngen, based in Beijing, is a biotechnology company pioneering the development of next-generation siRNA drugs to silence specific mRNAs and reduce the...
Read More
70 Hits youngen Aug 14, 2025, 9:05 AM
Youngen, based in Beijing, is a biotechnology company pioneering the development of next-generation siRNA drugs to silence specific mRNAs and reduce the...
Read More
55 Hits youngen Aug 14, 2025, 9:04 AM
Youngen, based in Beijing, is a biotechnology company pioneering the development of next-generation siRNA drugs to silence specific mRNAs and reduce the...
Read More
80 Hits youngen Aug 14, 2025, 9:03 AM
Youngen, based in Beijing, is a biotechnology company pioneering the development of next-generation siRNA drugs to silence specific mRNAs and reduce the...
Read More
Most Popular
Sep 10, 2025, 3:13 PM youngen
Sep 10, 2025, 3:14 PM youngen
Apr 9, 2026, 8:10 AM youngen
Apr 9, 2026, 8:11 AM youngen
Apr 9, 2026, 8:13 AM youngen
Apr 9, 2026, 8:14 AM youngen
Dec 17, 2025, 8:16 AM youngen